Drug Profile
Research programme: anti-interleukin-5 receptor monoclonal antibodies - Biocad
Alternative Names: Anti IL-5R MAB - BiocadLatest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Biocad
- Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for research development in Autoimmune-disorders in Russia (Parenteral)
- 29 Jan 2018 Early research in Autoimmune disorders in Russia (Parenteral) before January 2018 (Biocad pipeline, January 2018)